Orthofix Medical Inc. Inventory, Finished Goods, Net of Reserves
Orthofix Medical Inc. (OFIX) had Inventory, Finished Goods, Net of Reserves of $89.20 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-08-05
- 2026-06-30: Inventory, Finished Goods, Net of Reserves $89.20M.
- 2026-03-31: Inventory, Finished Goods, Net of Reserves $87.74M.
- 2025-12-31: Inventory, Finished Goods, Net of Reserves $86.20M.
- 2025-09-30: Inventory, Finished Goods, Net of Reserves $88.29M.
| Period end | Inventory, Finished Goods, Net of Reserves | Inventory, Finished Goods, Net of Reserves as first filed |
|---|---|---|
| 2026-06-30 | $89.20M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $87.74M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $86.20M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $88.29M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $85.00M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $91.60M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $105.35M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $117.55M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $123.47M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $131.98M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $140.27M 10-K · filed 2025-02-25 | |
| 2023-09-30 | $140.69M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $140.17M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $140.32M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $63.87M 10-K · filed 2024-03-05 | |
| 2022-09-30 | $66.23M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $26.28M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $24.55M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $58.29M 10-K · filed 2023-03-06 | $15.15M 10-K · filed 2022-02-25 |
| 2021-09-30 | $17.16M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $14.65M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $20.00M 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $29.14M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $26.38M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $28.68M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $35.24M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $20.71M 10-K · filed 2021-02-26 | |
| 2019-09-30 | $62.70M 10-Q · filed 2019-10-28 | |
| 2019-06-30 | $59.97M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $60.33M 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $18.24M 10-K · filed 2020-02-24 | |
| 2018-09-30 | $59.63M 10-Q · filed 2018-10-29 | |
| 2018-06-30 | $59.02M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $58.13M 10-Q · filed 2018-04-30 | |
| 2017-12-31 | $11.24M 10-K · filed 2019-02-25 | |
| 2017-09-30 | $58.96M 10-Q · filed 2017-10-30 | |
| 2017-06-30 | $55.71M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $47.11M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $15.98M 10-K · filed 2018-02-26 | |
| 2016-09-30 | $48.36M 10-Q · filed 2016-10-31 | |
| 2016-06-30 | $40.48M 10-Q · filed 2016-08-01 | |
| 2016-03-31 | $46.07M 10-Q · filed 2016-04-28 | |
| 2015-12-31 | $23.16M 10-K · filed 2017-02-27 | |
| 2015-09-30 | $44.69M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $44.31M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $42.45M 10-Q · filed 2015-05-18 | |
| 2014-12-31 | $24.95M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $47.94M 10-Q · filed 2015-03-31 | |
| 2014-06-30 | $50.70M 10-Q · filed 2015-03-31 | |
| 2014-03-31 | $51.19M 10-Q/A · filed 2015-03-31 | $40.76M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $28.29M 10-K · filed 2015-04-29 | $36.90M 10-Q · filed 2014-05-08 |
| 2012-12-31 | $22.24M 10-K/A · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |